TY - JOUR T1 - Review: verteporfin plus photodynamic therapy reduces loss of vision in age related macular degeneration JF - Evidence Based Medicine JO - Evid Based Med SP - 20 LP - 20 DO - 10.1136/ebm.9.1.20 VL - 9 IS - 1 A2 - , Y1 - 2004/01/01 UR - http://ebm.bmj.com/content/9/1/20.abstract N2 - Wormald R, Evans J, Smeeth L, et al. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2003;(3):CD002030 (latest version 25 Feb 2003).OpenUrl 
 
 Q In patients with neovascular age related macular degeneration (AMD), what is the effect of photodynamic therapy? Clinical impact ratings GP/FP/Primary care ★★★★☆☆☆ Data sources: Cochrane Central Register of Controlled Trials, Medline, EMBASE/Excerpta Medica (to January 2003), Science Citation Index; reference lists; and contact with experts. Study selection and assessment: randomised controlled trials that compared photodynamic therapy with placebo, no treatment, or another treatment in people with neovascular AMD. Outcome: prevention of visual loss. 2 studies (948 participants) were included. Both studies compared verteporfin, 6 mg/m2 (intravenous infusion of 30 ml/10 min), plus … ER -